Top Biotechnology Startups in 2026

Mammoth biosciences is harnessing the diversity of nature to power the next generation of crispr products. through its discovery of novel crispr systems, the company is enabling the full potential of its platform to read and write the code of life. with a distinguished team including co-founder and crispr-cas gene editing co-inventor jennifer doudna, mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

We help solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

emeraldcloudlab.com emeraldtherapeutics.com

Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.

Myome helps identify genes that cause disease and act based on leading science. The data is secure, portable, and reusable throughout life.

Be Golden is an early stage, YC-backed, female-founded health tech start-up that helps people measure and manage their inflammation levels. Chronic inflammation impacts a variety of health issues from IVF failure, to IBS, to cancer and heart disease. This is a great opportunity to get in at the ground floor and build out a new category of health tech product. If you are a builder excited about creating delightful and unique digital health experiences, come join us! *How the product works* Customers use at home finger prick blood testing and a digital platform to help manage inflammation levels via lifestyle choices. We are building out a web application to help people track their biomarkers and activity data to lower their inflammation levels and improve their health.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology. Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.

Cultivated Pork

We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity.